title: 3,4-Diaminopyridine may improve myasthenia gravis with MuSK antibodies.
authors.affiliation: From the Institute of Neurology, Catholic University, Rome, Italy. a.evoli@rm.unicatt.it.
authors.forename: Amelia
authors.initials: A
authors.lastname: Evoli
authors.affiliation: From the Institute of Neurology, Catholic University, Rome, Italy.
authors.forename: Paolo E
authors.initials: PE
authors.lastname: Alboini
authors.affiliation: From the Institute of Neurology, Catholic University, Rome, Italy.
authors.forename: Valentina
authors.initials: V
authors.lastname: Damato
authors.affiliation: From the Institute of Neurology, Catholic University, Rome, Italy.
authors.forename: Raffaele
authors.initials: R
authors.lastname: Iorio
mesh_terms: D015761:4-Aminopyridine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077770:Amifampridine; D001323:Autoantibodies / Q000097:blood*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000097:blood* / Q000175:diagnosis / Q000188:drug therapy*; D020794:Receptor Protein-Tyrosine Kinases / Q000097:blood*; D011950:Receptors, Cholinergic / Q000097:blood*
chemical_list: D001323:Autoantibodies; D011950:Receptors, Cholinergic; D015761:4-Aminopyridine; C095714:MUSK protein, human; D020794:Receptor Protein-Tyrosine Kinases; D000077770:Amifampridine